Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse

Prof David Marks - University Hospital Bristol, Bristol, UK
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )
24 May 2019

CNS involvement and prophylaxis in acute lymphoblastic leukaemia

Dr Mark Litzow - Mayo Clinic, Rochester, USA
CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
24 May 2019

Using CAR T cells for the treatment of acute lymphoblastic leukaemia

Prof Claudia Rossig - Universität Münster, Münster, Germany
Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )
24 May 2019

Myeloma bone disease: Clinical features and complications

Dr Andrew Chantry - University of Sheffield, Sheffield, UK
Myeloma bone disease: Clinical features and complications ( Dr Andrew Chantry - University of Sheffield, Sheffield, UK )
14 May 2019

Should you start treatment early in smouldering multiple myeloma?

Dr Albert Oriol - Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Should you start treatment early in smouldering multiple myeloma? ( Dr Albert Oriol - Josep Carreras Leukaemia Research Institute, Barcelona, Spain )
14 May 2019

Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
14 May 2019

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA
Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019

Role of interventional oncology for immunology treatment

Prof Thierry De Baere - Institut Gustave Roussy, Paris, France
Role of interventional oncology for immunology treatment ( Prof Thierry De Baere - Institut Gustave Roussy, Paris, France )
8 May 2019

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019